The Early Manifest Glaucoma Trial (EMGT), reported in the January issue of the Archives of Ophthalmology, provides conclusive evidence that reduction in intraocular pressure (IOP) lowers the risk of progression in early open-angle glaucoma.
This has significant public health implications. “Patients treated in the EMGT had half of the progression risk of control patients,” write M. Cristina Leske, MD, MPH, from Stony Brook University School of Medicine in New York, and colleagues from the EMGT Group. “The magnitude of initial IOP reduction was a major factor influencing outcome.”
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!